Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
36.44
+0.33 (0.90%)
Jun 10, 2026, 2:06 PM EDT - Market open
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $2.22 billion as of June 10, 2026. Its market cap has increased by 175.75% in one year.
Market Cap
2.22B
Enterprise Value
1.75B
1-Year Change
175.75%
Ranking
Category
Stock Price
$36.44
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $2.22B, an increase of 127.83%. That is a compound annual growth rate of 28.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 2.20B | 140.63% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 2.24B |
| Pharvaris | 2.20B |
| Ultragenyx Pharmaceutical | 2.12B |
| Immunome | 2.11B |
| Aurinia Pharmaceuticals | 2.01B |
| Trevi Therapeutics | 1.92B |
| Nektar Therapeutics | 1.91B |
| Intellia Therapeutics | 1.88B |